Global and Japan Gastrointestinal Drugs Market Insights, Forecast to 2026

Global and Japan Gastrointestinal Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Gastrointestinal Drugs Product Introduction
1.2 Market Segments
1.3 Key Gastrointestinal Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gastrointestinal Drugs Market Size Growth Rate by Type
1.4.2 Prescription Gastrointestinal Drug
1.4.3 OTC Gastrointestinal Drug
1.5 Market by Application
1.5.1 Global Gastrointestinal Drugs Market Size Growth Rate by Application
1.5.2 Chronic Gastritis
1.5.3 Functional Dyspepsia
1.5.4 Peptic Ulcer
1.5.5 Acute Gastroenteritis
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Drugs Market Size, Estimates and Forecasts
2.1.1 Global Gastrointestinal Drugs Revenue 2015-2026
2.1.2 Global Gastrointestinal Drugs Sales 2015-2026
2.2 Global Gastrointestinal Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Gastrointestinal Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Gastrointestinal Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Gastrointestinal Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Gastrointestinal Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Gastrointestinal Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Gastrointestinal Drugs Revenue Forecast by Region (2021-2026)
3 Global Gastrointestinal Drugs Competitor Landscape by Players
3.1 Global Top Gastrointestinal Drugs Sales by Manufacturers
3.1.1 Global Gastrointestinal Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Gastrointestinal Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Gastrointestinal Drugs Manufacturers by Revenue
3.2.1 Global Gastrointestinal Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Gastrointestinal Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gastrointestinal Drugs Revenue in 2019
3.2.5 Global Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Gastrointestinal Drugs Price by Manufacturers
3.4 Global Gastrointestinal Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gastrointestinal Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastrointestinal Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Gastrointestinal Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastrointestinal Drugs Market Size by Type (2015-2020)
4.1.1 Global Gastrointestinal Drugs Sales by Type (2015-2020)
4.1.2 Global Gastrointestinal Drugs Revenue by Type (2015-2020)
4.1.3 Gastrointestinal Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gastrointestinal Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Gastrointestinal Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Gastrointestinal Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Gastrointestinal Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gastrointestinal Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gastrointestinal Drugs Market Size by Application (2015-2020)
5.1.1 Global Gastrointestinal Drugs Sales by Application (2015-2020)
5.1.2 Global Gastrointestinal Drugs Revenue by Application (2015-2020)
5.1.3 Gastrointestinal Drugs Price by Application (2015-2020)
5.2 Gastrointestinal Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Gastrointestinal Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Gastrointestinal Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Gastrointestinal Drugs Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Gastrointestinal Drugs Market Size YoY Growth 2015-2026
6.1.1 Japan Gastrointestinal Drugs Sales YoY Growth 2015-2026
6.1.2 Japan Gastrointestinal Drugs Revenue YoY Growth 2015-2026
6.1.3 Japan Gastrointestinal Drugs Market Share in Global Market 2015-2026
6.2 Japan Gastrointestinal Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Gastrointestinal Drugs Players by Sales (2015-2020)
6.2.2 Japan Top Gastrointestinal Drugs Players by Revenue (2015-2020)
6.3 Japan Gastrointestinal Drugs Historic Market Review by Type (2015-2020)
6.3.1 Japan Gastrointestinal Drugs Sales Market Share by Type (2015-2020)
6.3.2 Japan Gastrointestinal Drugs Revenue Market Share by Type (2015-2020)
6.3.3 Japan Gastrointestinal Drugs Price by Type (2015-2020)
6.4 Japan Gastrointestinal Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Gastrointestinal Drugs Sales Forecast by Type (2021-2026)
6.4.2 Japan Gastrointestinal Drugs Revenue Forecast by Type (2021-2026)
6.4.3 Japan Gastrointestinal Drugs Price Forecast by Type (2021-2026)
6.5 Japan Gastrointestinal Drugs Historic Market Review by Application (2015-2020)
6.5.1 Japan Gastrointestinal Drugs Sales Market Share by Application (2015-2020)
6.5.2 Japan Gastrointestinal Drugs Revenue Market Share by Application (2015-2020)
6.5.3 Japan Gastrointestinal Drugs Price by Application (2015-2020)
6.6 Japan Gastrointestinal Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Gastrointestinal Drugs Sales Forecast by Application (2021-2026)
6.6.2 Japan Gastrointestinal Drugs Revenue Forecast by Application (2021-2026)
6.6.3 Japan Gastrointestinal Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Gastrointestinal Drugs Market Size YoY Growth 2015-2026
7.2 North America Gastrointestinal Drugs Market Facts & Figures by Country
7.2.1 North America Gastrointestinal Drugs Sales by Country (2015-2020)
7.2.2 North America Gastrointestinal Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Gastrointestinal Drugs Market Size YoY Growth 2015-2026
8.2 Europe Gastrointestinal Drugs Market Facts & Figures by Country
8.2.1 Europe Gastrointestinal Drugs Sales by Country
8.2.2 Europe Gastrointestinal Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Gastrointestinal Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Gastrointestinal Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Gastrointestinal Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Gastrointestinal Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Gastrointestinal Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Gastrointestinal Drugs Market Facts & Figures by Country
10.2.1 Latin America Gastrointestinal Drugs Sales by Country
10.2.2 Latin America Gastrointestinal Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Gastrointestinal Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Gastrointestinal Drugs Sales by Country
11.2.2 Middle East and Africa Gastrointestinal Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca Gastrointestinal Drugs Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Gastrointestinal Drugs Products Offered
12.2.5 Sanofi Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Description and Business Overview
12.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer Gastrointestinal Drugs Products Offered
12.3.5 Bayer Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Gastrointestinal Drugs Products Offered
12.4.5 Pfizer Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Description and Business Overview
12.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.5.4 GlaxoSmithKline Gastrointestinal Drugs Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Teva
12.6.1 Teva Corporation Information
12.6.2 Teva Description and Business Overview
12.6.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teva Gastrointestinal Drugs Products Offered
12.6.5 Teva Recent Development
12.7 Zeria?Tillotts?
12.7.1 Zeria?Tillotts? Corporation Information
12.7.2 Zeria?Tillotts? Description and Business Overview
12.7.3 Zeria?Tillotts? Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Zeria?Tillotts? Gastrointestinal Drugs Products Offered
12.7.5 Zeria?Tillotts? Recent Development
12.8 Perrigo
12.8.1 Perrigo Corporation Information
12.8.2 Perrigo Description and Business Overview
12.8.3 Perrigo Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Perrigo Gastrointestinal Drugs Products Offered
12.8.5 Perrigo Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Corporation Information
12.9.2 Boehringer Ingelheim Description and Business Overview
12.9.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Boehringer Ingelheim Gastrointestinal Drugs Products Offered
12.9.5 Boehringer Ingelheim Recent Development
12.10 Purdue Pharma
12.10.1 Purdue Pharma Corporation Information
12.10.2 Purdue Pharma Description and Business Overview
12.10.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Purdue Pharma Gastrointestinal Drugs Products Offered
12.10.5 Purdue Pharma Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.11.4 AstraZeneca Gastrointestinal Drugs Products Offered
12.11.5 AstraZeneca Recent Development
12.12 Abbott
12.12.1 Abbott Corporation Information
12.12.2 Abbott Description and Business Overview
12.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Abbott Products Offered
12.12.5 Abbott Recent Development
12.13 Jiangzhong
12.13.1 Jiangzhong Corporation Information
12.13.2 Jiangzhong Description and Business Overview
12.13.3 Jiangzhong Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Jiangzhong Products Offered
12.13.5 Jiangzhong Recent Development
12.14 Xian-Janssen
12.14.1 Xian-Janssen Corporation Information
12.14.2 Xian-Janssen Description and Business Overview
12.14.3 Xian-Janssen Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Xian-Janssen Products Offered
12.14.5 Xian-Janssen Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Gastrointestinal Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastrointestinal Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Gastrointestinal Drugs Market Segments
Table 2. Ranking of Global Top Gastrointestinal Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gastrointestinal Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Prescription Gastrointestinal Drug
Table 5. Major Manufacturers of OTC Gastrointestinal Drug
Table 6. Global Gastrointestinal Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Gastrointestinal Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Gastrointestinal Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Gastrointestinal Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Gastrointestinal Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Gastrointestinal Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Gastrointestinal Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Gastrointestinal Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Drugs as of 2019)
Table 16. Gastrointestinal Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Gastrointestinal Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Gastrointestinal Drugs Price (2015-2020) (USD/Unit)
Table 19. Gastrointestinal Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Gastrointestinal Drugs Product Type
Table 21. Date of International Manufacturers Enter into Gastrointestinal Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Gastrointestinal Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Gastrointestinal Drugs Sales Share by Type (2015-2020)
Table 25. Global Gastrointestinal Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Gastrointestinal Drugs Revenue Share by Type (2015-2020)
Table 27. Gastrointestinal Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Gastrointestinal Drugs Sales Share by Type (2021-2026)
Table 29. Global Gastrointestinal Drugs Sales by Application (2015-2020) (K Units)
Table 30. Global Gastrointestinal Drugs Sales Share by Application (2015-2020)
Table 31. Global Gastrointestinal Drugs Sales Share by Application (2021-2026)
Table 32. Global Gastrointestinal Drugs Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Gastrointestinal Drugs Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Gastrointestinal Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Gastrointestinal Drugs Sales (K Units) of Key Companies (2015-2020)
Table 36. Japan Gastrointestinal Drugs Sales Share by Company (2015-2020)
Table 37. Japan Gastrointestinal Drugs Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Gastrointestinal Drugs Sales (K Units) by Type (2015-2020)
Table 39. Japan Gastrointestinal Drugs Sales Share by Type (2015-2020)
Table 40. Japan Gastrointestinal Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Gastrointestinal Drugs Price (K Units) by Type (2015-2020)
Table 42. Japan Gastrointestinal Drugs Sales (K Units) by Type (2021-2026)
Table 43. Japan Gastrointestinal Drugs Sales Share by Type (2021-2026)
Table 44. Japan Gastrointestinal Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Gastrointestinal Drugs Revenue Share by Type (2021-2026)
Table 46. Japan Gastrointestinal Drugs Price (K Units) by Type (2021-2026)
Table 47. Japan Gastrointestinal Drugs Sales (K Units) by Application (2015-2020)
Table 48. Japan Gastrointestinal Drugs Sales Share by Application (2015-2020)
Table 49. Japan Gastrointestinal Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Gastrointestinal Drugs Sales (K Units) by Application (2021-2026)
Table 51. Japan Gastrointestinal Drugs Sales Share by Application (2021-2026)
Table 52. Japan Gastrointestinal Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Gastrointestinal Drugs Revenue Share by Application (2021-2026)
Table 54. North America Gastrointestinal Drugs Sales by Country (2015-2020) (K Units)
Table 55. North America Gastrointestinal Drugs Sales Market Share by Country (2015-2020)
Table 56. North America Gastrointestinal Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Gastrointestinal Drugs Revenue Market Share by Country (2015-2020)
Table 58. Europe Gastrointestinal Drugs Sales by Country (2015-2020) (K Units)
Table 59. Europe Gastrointestinal Drugs Sales Market Share by Country (2015-2020)
Table 60. Europe Gastrointestinal Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Gastrointestinal Drugs Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Gastrointestinal Drugs Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Gastrointestinal Drugs Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Gastrointestinal Drugs Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Gastrointestinal Drugs Revenue Market Share by Region (2015-2020)
Table 66. Latin America Gastrointestinal Drugs Sales by Country (2015-2020) (K Units)
Table 67. Latin America Gastrointestinal Drugs Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Gastrointestinal Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Gastrointestinal Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Gastrointestinal Drugs Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Gastrointestinal Drugs Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Gastrointestinal Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Country (2015-2020)
Table 74. AstraZeneca Corporation Information
Table 75. AstraZeneca Description and Business Overview
Table 76. AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. AstraZeneca Gastrointestinal Drugs Product
Table 78. AstraZeneca Recent Development
Table 79. Sanofi Corporation Information
Table 80. Sanofi Description and Business Overview
Table 81. Sanofi Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Sanofi Product
Table 83. Sanofi Recent Development
Table 84. Bayer Corporation Information
Table 85. Bayer Description and Business Overview
Table 86. Bayer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Bayer Product
Table 88. Bayer Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Business Overview
Table 91. Pfizer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. GlaxoSmithKline Corporation Information
Table 95. GlaxoSmithKline Description and Business Overview
Table 96. GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Recent Development
Table 99. Teva Corporation Information
Table 100. Teva Description and Business Overview
Table 101. Teva Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Teva Product
Table 103. Teva Recent Development
Table 104. Zeria(Tillotts) Corporation Information
Table 105. Zeria(Tillotts) Description and Business Overview
Table 106. Zeria(Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Zeria(Tillotts) Product
Table 108. Zeria(Tillotts) Recent Development
Table 109. Perrigo Corporation Information
Table 110. Perrigo Description and Business Overview
Table 111. Perrigo Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Perrigo Product
Table 113. Perrigo Recent Development
Table 114. Boehringer Ingelheim Corporation Information
Table 115. Boehringer Ingelheim Description and Business Overview
Table 116. Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Boehringer Ingelheim Product
Table 118. Boehringer Ingelheim Recent Development
Table 119. Purdue Pharma Corporation Information
Table 120. Purdue Pharma Description and Business Overview
Table 121. Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Purdue Pharma Product
Table 123. Purdue Pharma Recent Development
Table 124. C.B. Fleet Corporation Information
Table 125. C.B. Fleet Description and Business Overview
Table 126. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. C.B. Fleet Product
Table 128. C.B. Fleet Recent Development
Table 129. Abbott Corporation Information
Table 130. Abbott Description and Business Overview
Table 131. Abbott Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Abbott Product
Table 133. Abbott Recent Development
Table 134. Jiangzhong Corporation Information
Table 135. Jiangzhong Description and Business Overview
Table 136. Jiangzhong Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Jiangzhong Product
Table 138. Jiangzhong Recent Development
Table 139. Xian-Janssen Corporation Information
Table 140. Xian-Janssen Description and Business Overview
Table 141. Xian-Janssen Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Xian-Janssen Product
Table 143. Xian-Janssen Recent Development
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key Gastrointestinal Drugs Players
Table 148. Gastrointestinal Drugs Customers List
Table 149. Gastrointestinal Drugs Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal Drugs Product Picture
Figure 2. Global Gastrointestinal Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Prescription Gastrointestinal Drug Product Picture
Figure 4. OTC Gastrointestinal Drug Product Picture
Figure 5. Global Gastrointestinal Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Chronic Gastritis
Figure 7. Functional Dyspepsia
Figure 8. Peptic Ulcer
Figure 9. Acute Gastroenteritis
Figure 10. Other
Figure 11. Gastrointestinal Drugs Report Years Considered
Figure 12. Global Gastrointestinal Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Gastrointestinal Drugs Sales 2015-2026 (K Units)
Figure 14. Global Gastrointestinal Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Gastrointestinal Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Gastrointestinal Drugs Sales Market Share by Region in 2019
Figure 17. Global Gastrointestinal Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Gastrointestinal Drugs Revenue Market Share by Region in 2019
Figure 19. Global Gastrointestinal Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Gastrointestinal Drugs Revenue in 2019
Figure 21. Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Gastrointestinal Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Gastrointestinal Drugs Sales Market Share by Type in 2019
Figure 24. Global Gastrointestinal Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Gastrointestinal Drugs Revenue Market Share by Type in 2019
Figure 26. Global Gastrointestinal Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Gastrointestinal Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Gastrointestinal Drugs Sales Market Share by Application in 2019
Figure 29. Global Gastrointestinal Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Gastrointestinal Drugs Revenue Market Share by Application in 2019
Figure 31. Japan Gastrointestinal Drugs Sales Growth Rate 2015-2026 (K Units)
Figure 32. Japan Gastrointestinal Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. Japan Gastrointestinal Drugs Market Share in Global Market 2015-2026
Figure 34. Japan 5 and 10 Largest Gastrointestinal Drugs Players Market Share by Revenue in Gastrointestinal Drugs in 2019
Figure 35. Japan Gastrointestinal Drugs Revenue Share by Type (2015-2020)
Figure 36. Japan Gastrointestinal Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 37. Japan Gastrointestinal Drugs Revenue Share by Application (2015-2020)
Figure 38. Japan Gastrointestinal Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Gastrointestinal Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. North America Gastrointestinal Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Gastrointestinal Drugs Sales Market Share by Country in 2019
Figure 42. North America Gastrointestinal Drugs Revenue Market Share by Country in 2019
Figure 43. U.S. Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. U.S. Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Canada Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Gastrointestinal Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 48. Europe Gastrointestinal Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Gastrointestinal Drugs Sales Market Share by Country in 2019
Figure 50. Europe Gastrointestinal Drugs Revenue Market Share by Country in 2019
Figure 51. Germany Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Germany Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. France Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 56. U.K. Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 58. Italy Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. Russia Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Asia Pacific Gastrointestinal Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 62. Asia Pacific Gastrointestinal Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Gastrointestinal Drugs Sales Market Share by Region in 2019
Figure 64. Asia Pacific Gastrointestinal Drugs Revenue Market Share by Region in 2019
Figure 65. China Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. China Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Japan Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. South Korea Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. India Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Australia Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Taiwan Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Indonesia Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Thailand Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 82. Malaysia Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 84. Philippines Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 86. Vietnam Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Latin America Gastrointestinal Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Gastrointestinal Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Gastrointestinal Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Gastrointestinal Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Middle East and Africa Gastrointestinal Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Gastrointestinal Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Gastrointestinal Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Gastrointestinal Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Gastrointestinal Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Porter's Five Forces Analysis
Figure 108. Gastrointestinal Drugs Value Chain
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs